John D. Briggs

Fraunhofer USA Center for Manufacturing Innovation

Papers

1

Total Citations

60

H-Index

1

About

John D. Briggs is a pioneering figure in the field of molecular pharming, where his work has revolutionized the production of plant-based vaccines and pharmaceuticals. His most influential contribution is the development of the first fully automated "factory" that leverages tobacco plants to rapidly produce large quantities of therapeutic biologics, including vaccines. This breakthrough, detailed in his 2012 paper (cited over 60 times), harnesses a plant viral vector technology to synthesize specific proteins within the leaves of fast-growing tobacco, slashing production timelines from months to mere weeks. Briggs’s innovation addresses critical bottlenecks in traditional biomanufacturing—such as cost, scalability, and speed—making it a game-changer for pandemic response and global health equity. Beyond this landmark achievement, his research has advanced the integration of automation and synthetic biology in plant systems, earning him recognition as a leader in sustainable bioproduction. With a citation impact that underscores his work’s relevance, Briggs continues to inspire efforts to transform agriculture into a platform for life-saving medicines.

Research Focus

Key Achievements

1
H-Index
1
Papers
60
Total Citations
60
Avg Citations/Paper
🏆 Most Cited Paper
Automated Production of Plant-Based Vaccines and Pharmaceuticals
60 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Fraunhofer USA Center for Manufacturing Innovation

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago